begin privacyenhanced message proctype 2001micclear originatorname webmasterwwwsecgov originatorkeyasymmetric mfgwcgyevqgbaqicaf8dsgawrwjaw2snkk9avtbzyzmr6agjlwyk3xmzv3dtinen twsm7vrzladbmyqaionwg5sdw3p6oam5d3tdezxmm7z1tbtwidaqab micinfo rsamd5rsa aju2f4tbhim8iulkocetrunvxfmsnqdu5nnbn9hwikbjqewcxgnt2mjx5rgmg 6bzoorbt0wgtlm8cun6oqg 000095012310031390txt 20100401 000095012310031390hdrsgml 20100401 20100401144515 accession number 000095012310031390 conformed submission type sc 14d9a public document count 1 filed date 20100401 date change 20100401 subject company company data company conformed name global med technology inc central index key 0001009463 standard industrial classification servicesprepackaged software 7372 irs number 841116894 state incorporation co fiscal year end 1231 filing value form type sc 14d9a sec act 1934 act sec file number 00554591 film number 10723447 business address street 1 12600 w colfax street 2 suite c420 city lakewood state co zip 80215 business phone 3032382000 mail address street 1 12600 west colfax avenue street 2 suite c420 city lakewood state co zip 801253737 former company former conformed name global data technology inc date name change 19960808 filed by company data company conformed name global med technology inc central index key 0001009463 standard industrial classification servicesprepackaged software 7372 irs number 841116894 state incorporation co fiscal year end 1231 filing value form type sc 14d9a business address street 1 12600 w colfax street 2 suite c420 city lakewood state co zip 80215 business phone 3032382000 mail address street 1 12600 west colfax avenue street 2 suite c420 city lakewood state co zip 801253737 former company former conformed name global data technology inc date name change 19960808 sc 14d9a 1 g22782sc14d9zahtm sc 14d9a sc14d9za united state security exchange commission washington dc 20549 schedule 14d9 solicitationrecommendation statement section 14d4 security exchange act 1934 amendment no 4 global med technology inc name subject company global med technology inc name person filing statement common stock par value 001 per share series convertible preferred stock par value 001 per share title class security 37935e101 cusip number class security michael i ruxin md chief executive officer global med technology inc 12600 west colfax suite c420 lakewood co 80215 303 2382000 name address telephone number person authorized receive notice communication behalf person filing statement copy to clayton e parker martin t schrier kl gate llp 200 s biscayne boulevard suite 3900 miami florida 33131 305 5393300 check box filing relates solely preliminary communication made commencement tender offer amendment no 4 solicitationrecommendation statement schedule 14d9 amends supplement solicitationrecommendation statement schedule 14d9 filed global med technology inc colorado corporation “global med” security exchange commission the “sec” march 4 2010 a amended supplemented time time “schedule 14d9” schedule 14d9 relates offer haemonetics corporation massachusetts corporation “haemonetics” wholly owned subsidiary atlas acquisition corp colorado corporation “purchaser” purchase outstanding share global med’s common stock 001 par value per share the “global med common stock” outstanding share global med’s series convertible preferred stock 001 par value per share the “global med preferred stock” upon term subject condition set forth haemonetics’ offer purchase dated february 19 2010 a amended supplemented time time “offer purchase” offer purchase attached exhibit a1a schedule filed haemonetics sec february 19 2010 a amended supplemented time time “schedule to” term offer a defined below set forth offer purchase related letter transmittal global med common stock letter transmittal global med preferred stock each context requires “letter transmittal” together offer purchase “offer” capitalized term used otherwise defined herein shall respective meaning ascribed term schedule 14d9 item 8 schedule 14d9 hereby amended supplemented adding following immediately subheading entitled “forward looking statements” “m expiration subsequent offering period exercise topup option 1200 midnight boston massachusetts time march 31 2010 subsequent offering period expired extended marking conclusion offer based information provided computershare trust company na haemonetics expiration subsequent offering period 3960 share global med preferred stock approximately 34398052 share global med common stock tendered withdrawn offer including share tendered subsequent offering period tendered share constituted 100 share global med preferred stock outstanding approximately 897 share global med common stock outstanding purchaser accepted payment share validly tendered pursuant term merger agreement purchaser exercised topup option increase ownership global med common stock least one share 90 number share global med common stock outstanding after giving effect issuance share global med common stock pursuant topup option described merger agreement purchase price per share global med common stock sold purchaser connection exercise topup option equal common stock offer price the “topup option purchase price” aggregate topup option purchase price paid purchaser secured promissory note principal amount equal topup option purchase price multiplied number topup option share haemonetics advised global med intends complete acquisition global med merging purchaser global med way “short form” merger without vote meeting shareholder global med accordance applicable provision colorado law merger remaining publiclyheld share global med common stock other share global med common stock dissenters’ right validly exercised perfected applicable colorado law converted right receive 122 per share global med common stock net holder cash without interest le applicable withholding tax representing price paid offer colorado law haemonetics required give ten days’ prior notice merger remaining shareholder global med haemonetics informed global med expects complete merger promptly thereafter following merger global med become whollyowned subsidiary haemonetics share global med common stock longer eligible quotation otc bulletin board april 1 2010 haemonetics purchaser issued press release announcing conclusion offer full text press release issued haemonetics purchaser set forth exhibit a12 hereto incorporated herein reference” 2 item 8 schedule 14d9 hereby amended supplemented changing subheading entitled “m forwardlooking statements” reflect following “n forwardlooking statements” item 9 schedule 14d9 hereby amended supplemented adding following “a12 press release issued haemonetics purchaser dated april 1 2010 incorporated reference exhibit a5d amendment no 6 schedule to” 3 signature due inquiry best knowledge belief certify information set forth statement true complete correct global med technology inc by s michael i ruxin md name michael i ruxin md title chief executive officer dated april 1 2010 4 end privacyenhanced message